The cost-effectiveness of treatment as prevention: analysis of the HPTN 052 trial

被引：0

作者：

Walensky, R. P. ^{[1
,2
,6
]}

Ross, E. L. ^{[1
]}

Kumarasamy, N. ^{[7
]}

Wood, R. ^{[8
,9
]}

Noubary, F. ^{[1
]}

Paltiel, A. D. ^{[10
]}

Nakamura, Y. M. ^{[1
]}

Godbole, S. ^{[11
]}

Hosseinipour, M. ^{[12
,13
]}

Hakim, J. G. ^{[14
]}

Kumwenda, J. ^{[15
]}

Makhema, J. ^{[5
]}

Akelo, V. ^{[16
]}

Panchia, R. ^{[17
]}

Sanne, I. ^{[18
]}

Weinstein, M. C. ^{[4
]}

Losina, E. ^{[3
,6
,19
]}

Mayer, K. H. ^{[20
]}

Grinsztejn, B. ^{[21
]}

Pilotto, J. ^{[22
,23
]}

Chariyalertsak, S. ^{[24
]}

Santos, B. ^{[25
]}

Chen, Y. Q. ^{[26
]}

Wang, L. ^{[26
]}

Li, X. ^{[26
]}

McCauley, M. ^{[27
]}

Gamble, T. ^{[28
]}

Piwowar-Manning, E. ^{[29
]}

Cottle, L. ^{[30
]}

Hoffman, I. ^{[31
]}

Eron, J. ^{[31
]}

Gallant, J. ^{[29
]}

Swindells, S. ^{[32
]}

Taha, T. ^{[33
]}

Nielsen-Saines, K. ^{[34
]}

Celentano, D. ^{[33
]}

Essex, M. ^{[4
]}

Elharrar, V. ^{[35
]}

Burns, D. ^{[35
]}

Seage, G. R. ^{[4
]}

Cohen, M. S. ^{[31
]}

Freedberg, K. A. ^{[1
,2
,19
]}

机构：

[1] Massachusetts Gen Hosp, Boston, MA 02114 USA

[2] Harvard Univ, Sch Med, Boston, MA USA

[3] Harvard Ctr AIDS Res, Boston, MA USA

[4] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA

[5] Botswana Harvard AIDS Inst, Gaborone, Botswana

[6] Brigham & Womens Hosp, Boston, MA 02115 USA

[7] YR Gaitonade Ctr AIDS Res & Educ, Madras, Tamil Nadu, India

[8] Univ Cape Town, ZA-7925 Cape Town, South Africa

[9] Desmond Tutu HIV Ctr, Cape Town, South Africa

[10] Yale Univ, Sch Med, New Haven, CT USA

[11] NARI, Pune, Maharashtra, India

[12] Univ N Carolina Chapel Hill, Lilongwe, Malawi

[13] UNC Project Malawi, Lilongwe, Malawi

[14] Univ Zimbabwe, Dept Med, Harare, Zimbabwe

[15] Coll Med Johns Hopkins Project, Blantyre, Malawi

[16] KEMRI CDC Res & Publ Hlth Collaborat, Kisumu, Kenya

[17] Univ Witwatersrand, PHRU, Johannesburg, South Africa

[18] Univ Witwatersrand, Dept Med, Johannesburg, South Africa

[19] Boston Univ, Sch Publ Hlth, Boston, MA USA

[20] Fenway Inst, Boston, MA USA

[21] Fiocruz MS, Inst Pesquisa Clin Evandro Chagas, BR-21045900 Rio De Janeiro, Brazil

[22] Fiocruz MS, Hosp Geral Nova Iguacu, BR-21045900 Rio De Janeiro, Brazil

[23] Fiocruz MS, Lab AIDS & Imunol Mol IOC, BR-21045900 Rio De Janeiro, Brazil

[24] Chiang Mai Univ, Res Inst Hlth Sci, Chiang Mai 50000, Thailand

[25] Hosp Nossa Senhora da Conceicao, Porto Alegre, RS, Brazil

[26] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Seattle, WA 98104 USA

[27] FHI 360, Washington, DC USA

[28] FHI 360, Durham, NC USA

[29] Johns Hopkins Sch Med, Baltimore, MD USA

[30] SCHARP, Seattle, WA USA

[31] Univ N Carolina, Sch Med, Chapel Hill, NC USA

[32] Univ Nebraska Med Ctr, Omaha, NE USA

[33] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA

[34] Univ Calif Los Angeles, David Geffen Sch Med, Div Infect Dis, Los Angeles, CA 90095 USA

[35] NIAID, NIH, Bethesda, MD 20892 USA

来源：

JOURNAL OF THE INTERNATIONAL AIDS SOCIETY | 2012年 / 15卷

关键词：

D O I：

暂无

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：116 / 117

页数：2

共 50 条

[1] HIV treatment as prevention and HPTN 052
Cohen, Myron S.
McCauley, Marybeth
Gamble, Theresa R.
CURRENT OPINION IN HIV AND AIDS, 2012, 7 (02) : 99 - 105
[2] HPTN 052 and the future of HIV treatment and prevention
Seale, Andy
Lazarus, Jeffrey V.
Grubb, Ian
Fakoya, Ade
Atun, Rifat
LANCET, 2011, 378 (9787): : 226 - 226
[3] Cost-Effectiveness of Prevention and Treatment of VTE
Nicolaides, A.
Fareed, J.
Kakkar, A. K.
Comerota, A. J.
Goldhaber, S. Z.
Hull, R.
Myers, K.
Samama, M.
Fletcher, J.
Kalodiki, E.
Bergqvist, D.
Bonnar, J.
Caprini, J. A.
Carter, C.
Conard, J.
Eklof, B.
Elalamy, I.
Gerotziafas, G.
Geroulakos, G.
Giannoukas, A.
Greer, I.
Griffin, M.
Kakkos, S.
Lassen, M. R.
Lowe, G. D. O.
Markel, A.
Prandoni, P.
Raskob, G.
Spyropoulos, A. C.
Turpie, A. G.
Walenga, J. M.
Warwick, D.
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2013, 19 (02) : 225 - 229
[4] COST-EFFECTIVENESS OF PREVENTION AND TREATMENT OF VTE
不详
INTERNATIONAL ANGIOLOGY, 2013, 32 (02) : 253 - 257
[5] Prevention of HIV Transmission and the HPTN 052 Study
Cohen, Myron S.
Gamble, Theresa
McCauley, Marybeth
ANNUAL REVIEW OF MEDICINE, VOL 71, 2020, 2020, 71 : 347 - 360
[6] Prevention and treatment of cardiovascular disease in Ethiopia: a cost-effectiveness analysis
Tolla, Mieraf Taddesse
Norheim, Ole Frithjof
Memirie, Solomon Tessema
Abdisa, Senbeta Guteta
Ababulgu, Awel
Jerene, Degu
Bertram, Melanie
Strand, Kirsten
Verguet, Stephane
Johansson, Kjell Arne
COST EFFECTIVENESS AND RESOURCE ALLOCATION, 2016, 14
[7] Cost-effectiveness of prevention and treatment of the diabetic foot - A Markov analysis
Ortegon, MM
Redekop, WK
Niessen, LW
DIABETES CARE, 2004, 27 (04) : 901 - 907
[8] Medicare's use of cost-effectiveness analysis for prevention (but not for treatment)
Chambers, James D.
Cangelosi, Michael J.
Neumann, Peter J.
HEALTH POLICY, 2015, 119 (02) : 156 - 163
[9] Prevention and treatment of cardiovascular disease in Ethiopia: a cost-effectiveness analysis
Mieraf Taddesse Tolla
Ole Frithjof Norheim
Solomon Tessema Memirie
Senbeta Guteta Abdisa
Awel Ababulgu
Degu Jerene
Melanie Bertram
Kirsten Strand
Stéphane Verguet
Kjell Arne Johansson
Cost Effectiveness and Resource Allocation, 14
[10] COST-EFFECTIVENESS ANALYSIS IN FIRE PREVENTION
Tuomas, Laine
INJURY PREVENTION, 2016, 22 : A301 - A301

← 1 2 3 4 5 →